Earnings Ahead

INCY - Incyte Corp.

61.68 -1.26 -2

Incyte Corp.

Incyte Corp.

About

Profile

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics.


Headquarters

Wilmington, Delaware, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

INCY



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Incyte reports mixed Q4 results; initiates FY24 outlook
  • Incyte Q4 2023 Earnings Preview
  • Incyte buys global rights for tafasitamab from MorphoSys
  • MorphoSys jumps amid report Novartis in takeover talks; Karyopharm surges in sympathy (update)
  • Agilent, Incyte to collaborate on companion diagnostics development
  • Incyte is the most overweight stock by hedge funds - BofA
  • Catalyst Watch: CES lights up tech, retail's ICR conference and bank earnings blitz
  • FDA’s new drug approvals for 2023 rise 51% from last year
  • Arcus, Bristol-Myers, and R1 RCM are Citi’s top stocks in healthcare
  • Why did Incyte stock go up today? Positive drug study
  • Biotechs post record gains in November amid improving outlook
  • Goldman Sachs cuts Incyte to hold, cites Jakafi outlook uncertainty
  • Xencor falls after royalty sale to Canada’s OMERS
  • Incyte Non-GAAP EPS of $1.10 beats by $0.04, revenue of $919M misses by $44.09M
  • Incyte Q3 2023 Earnings Preview
  • Incyte says study evaluating efficacy of ruxolitinib cream in children met primary endpoint
  • FDA approves GSK drug Ojjaara for myelofibrosis with anemia (update)
  • AbCellera, Incyte partner for antibody-based cancer drugs
  • Incyte Non-GAAP EPS of $0.99 beats by $0.12, revenue of $954.61M beats by $44.2M
  • Replimune, Incyte to collaborate on squamous cell carcinoma combo
PEERS
/XLV

XLV

Date Price Open High Low Vol Change
Jan 29 73.72 73.22
74.11
72.67
1.2M 0.78%
Jan 28 73.15 72.69
73.99
71.85
995K 0.70%
Jan 27 72.64 72.29
73.43
71.36
1.1M 0.07%
Jan 24 72.59 72.3
73.68
72.29
1.3M 0.08%
Jan 23 72.53 72.32
72.88
71.05
1.0M 0.17%
 
Jan 22 72.41 73.47
73.55
71.97
1.2M -1.44%
Jan 21 73.47 72.21
73.98
71.85
1.9M 2.14%
Jan 17 71.93 72.87
73
71.85
1.0M -0.75%
Jan 16 72.47 72.51
72.98
71.72
1.1M 0.01%
Jan 15 72.46 72.96
73.83
72.21
1.1M 0.74%
Jan 14 71.93 72.34
72.93
71.22
1.6M -0.61%
Jan 13 72.37 70.54
72.94
69.65
1.6M 2.59%
Jan 10 70.54 72.21
72.6
69.53
2.0M -3.54%
Jan 8 73.13 73.19
74.01
72.85
1.6M -0.08%
Jan 7 73.19 73.06
75.04
72.46
1.9M 1.78%
Jan 6 71.91 69.45
72.79
69.45
1.9M 3.27%
Jan 3 69.63 69.76
70.44
69.35
1.5M 0.14%
Jan 2 69.53 69.67
70.27
68.92
1.1M 0.67%
Dec 31, 2024 69.07 68.54
69.2
68.19
1.0M 0.95%
Dec 30, 2024 68.42 68.56
68.87
67.7
826K -1.17%
Dec 27, 2024 69.23 68.71
69.9
68.19
966K -0.47%
Dec 26, 2024 69.56 69.52
70.11
69.25
765K -0.5%
Dec 24, 2024 69.91 69.88
70.1
68.92
396K 0.10%
Dec 23, 2024 69.84 68.58
70.19
68.15
1.6M 1.45%
Dec 20, 2024 68.84 66.89
69.11
66.89
6.8M 2.65%
Dec 19, 2024 67.06 68.64
68.64
66.33
2.0M -0.73%
Dec 18, 2024 67.55 69.18
69.63
67.55
1.9M -2.67%
Dec 17, 2024 69.4 68.78
69.74
68.51
2.0M -0.57%
Dec 16, 2024 69.8 69.31
70.88
68.62
2.8M 1.82%
Dec 13, 2024 68.55 70.64
70.79
68.52
1.8M -3.22%
Dec 12, 2024 70.83 70.5
72.11
70.48
1.4M -2.29%
Dec 11, 2024 72.49 72.65
73.5
72.1
1.4M 0.01%
Dec 10, 2024 72.48 72.11
73.1
71.35
2.4M 0.51%
Dec 9, 2024 72.11 75.94
75.98
71.8
1.8M -5.02%
Dec 6, 2024 75.92 75.27
76.46
75.02
1.3M 1.33%
Dec 5, 2024 74.92 73.02
75.37
72.87
1.8M 0.40%
Dec 4, 2024 74.62 73.4
75.32
73.34
2.6M 3.60%
Dec 3, 2024 72.03 72.73
72.96
71.72
1.7M -1.65%
Dec 2, 2024 73.24 74.28
74.7
72.64
1.7M -1.81%
Nov 29, 2024 74.59 75.71
76.08
74.22
798K -1.14%
Nov 27, 2024 75.45 75
76.14
74.75
1.2M 0.87%
Nov 26, 2024 74.8 74.14
74.95
73.1
1.5M 1.74%
Nov 25, 2024 73.52 72.34
73.87
72.25
3.4M 2.51%
Nov 22, 2024 71.72 70.43
72
70.33
1.5M 1.89%
Nov 21, 2024 70.39 71.33
71.4
69.3
2.1M -0.93%
Nov 20, 2024 71.05 70.66
71.68
70.25
2.3M 0.69%
Nov 19, 2024 70.56 67.11
74.1
65.02
10.9M -8.33%
Nov 18, 2024 76.97 75.89
77.01
75.42
1.8M 1.45%
Nov 15, 2024 75.87 77.15
77.87
73.25
3.8M -2.39%
Nov 14, 2024 77.73 80.15
80.46
77.58
1.9M -3.42%
Nov 13, 2024 80.48 80.8
81.7
80.37
1.6M -0.12%
Nov 12, 2024 80.58 81.55
82.02
80.2
1.8M -1.17%
Nov 11, 2024 81.53 83.54
83.54
81.16
1.9M -2.22%
Nov 8, 2024 83.38 82.59
83.95
82.14
3.2M 1.26%
Nov 7, 2024 82.34 81
82.97
79.53
2.6M 1.72%
Nov 6, 2024 80.95 78.45
82.19
78.21
5.3M 4.75%
Nov 5, 2024 77.28 75.77
77.37
75.34
1.3M 2.02%
Nov 4, 2024 75.75 75.07
76.57
75.07
1.5M -0.5%
Nov 1, 2024 76.13 74.12
76.33
73.91
2.3M 2.71%
Oct 31, 2024 74.12 73.91
74.68
73.28
2.0M 0%